Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›CSOP›03174
03174

CSOP Hang Seng Biotech ETF

The 03174 Exchange Traded Fund (ETF) is provided by CSOP. It is built to track an index: Hang Seng Biotech Index. The 03174 ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

HK$3.26
N/A
Data as of 07/17/26
1D price range
N/A
52W price range
HK$2.84HK$4.40
YTD Perf.
-4.41%
YTD Flows
Annualized volatility
Fund AuM
€92M
Share class AuM
€92M
TTM Yield
Tracking Error
Tracking Difference
ISIN
HK0000756202
TER
0.99%
Inception date
7/20/2021
Issuer
Replication method
Dividend policy
Compare similar ETFs

No content available for this fund

API
PerformanceDec 31, 2025 - Jul 17, 2026
-20%-10%0%10%20%JANMARMAYJUL
Flows
Join for free to unlock

No content available for this fund

Latest 03174 news

No content available for this fund

FAQ about 03174

03174 is a Passive ETF. This ETF provides exposure to Biotechnology Equities.
03174 tracks the Hang Seng Biotech Index - HKD, through a optimized sampling replication method.
03174 carries a total expense ratio (TER) of 0.99%, indicating the annual cost for holding the fund.
03174 was introduced to the market on July 20, 2021. It trades on Hong Kong
CSOP Hang Seng Biotech ETF, 03174, is provided by CSOP. Learn more about CSOP here.
03174 oversees €92M in assets as of July 17, 2026.
03174 follows a distributing dividend policy, meaning it pays out income to investors.
The base currency of 03174 is HKD.

No content available for this fund

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight